Kate Lillard Tunstall discusses Indica Lab’s 12-year journey in digital pathology, the impact of AI, and the future of the industry
Overview:
In this episode of the Digital Pathology Place Podcast, Kate Lillard Tunstall, Chief Scientific Officer at Indica Labs, provides a comprehensive look into the company’s 12-year history in the field of digital pathology and shares insights into the creation and impact of HALO®, the gold-standard for tissue-based analysis. Aleks and Kate touch on Indica Labs’ unique offerings, including their Pharma Services division, and discuss the ways artificial intelligence has changed digital pathology over the last several years, with a focus on what the future holds for the field.